Dear friends:
The MRF is part of an exciting collaboration with a new non-profit called SHARE For Cures that was featured by the White House Cancer Moonshot Initiative. This study will help to understand use of immunotherapy drugs outside of clinical trials. We are looking for patients who are taking or have taken immunotherapy drugs (anti-PD-1 or anti-PDL-1 inhibitors), including Opdivo (nivolumab), Keytruda (pembrolizumab), and/or Tencentriq (atezolizumab). Patients will be asked to share whatever medical and wellness data that they feel comfortable sharing with researchers. You will create a user account on the SHARE For Cures website, securely connect to the patient portals of your medical providers and health and wellness apps that you use, and select to share the data collected for research. There will also be a survey about your immunotherapy use.
To participate, please email CancerMoonshot@SHAREForCures.org and reference "MRFImmuno” to request an invitation code. We encourage you to participate to help us better understand these drugs and help find more cures for melanoma patients. Your assistance in this research collaboration is very much appreciated.
Best,
Shelby – MRF
